<- Go Home

BioGaia AB (publ)

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.

Market Cap

SEK 10.7B

Volume

200.5K

Cash and Equivalents

SEK 622.3M

EBITDA

SEK 440.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 1.0B

Profit Margin

72.45%

52 Week High

SEK 139.70

52 Week Low

SEK 93.20

Dividend

6.55%

Price / Book Value

9.23

Price / Earnings

37.24

Price / Tangible Book Value

10.66

Enterprise Value

SEK 10.0B

Enterprise Value / EBITDA

22.35

Operating Income

SEK 423.2M

Return on Equity

21.00%

Return on Assets

15.87

Cash and Short Term Investments

SEK 622.3M

Debt

N/A

Equity

SEK 1.2B

Revenue

SEK 1.4B

Unlevered FCF

SEK 254.0M

Sector

Biotechnology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches